| In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| | 10-K/A | 10-K/A | 10-K/A | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Product sales | | | | | 341.8 | | | |
| Other | | | | | 76.5 | | | |
| Total revenues [+] | 326.5 | 472.0 | 494.0 | 432.5 | 418.3 | 124.4 | 80.9 | 85.4 |
| Licensing | | | | | 52.3 | | | |
| Products | | | | | 341.8 | 110.0 | 71.7 | 58.3 |
| Services | | | | | 24.1 | | | |
| Revenue growth | -30.8% | -4.4% | 14.2% | 3.4% | 236.3% | 53.8% | -5.3% | 39.4% |
| Cost of goods sold [+] | 107.2 | 230.0 | 161.3 | 96.3 | 88.5 | 20.3 | 12.0 | 14.2 |
| Cost of product sales | | | | | 78.5 | | | |
| Cost of services | | | | | 10.0 | | | |
| Gross profit | 219.4 | 242.0 | 332.6 | 336.2 | 329.8 | 104.1 | 68.9 | 71.2 |
| Gross margin | 67.2% | 51.3% | 67.3% | 77.7% | 78.8% | 83.7% | 85.2% | 83.3% |
| Selling, general and administrative | 286.6 | 227.8 | 178.2 | 169.5 | 160.3 | 72.3 | 59.2 | 53.1 |
| Research and development | 64.9 | 44.8 | 75.0 | 65.6 | 42.9 | 24.2 | 20.6 | 33.3 |
| Other operating expenses | | -101.2 | | | | | | |
| EBITDA [+] | -104.8 | 242.8 | 235.0 | 201.0 | 195.7 | 14.6 | -7.8 | -12.1 |
| EBITDA growth | -143.2% | 3.3% | 16.9% | 2.7% | 1236.0% | -289.0% | -36.1% | -83.6% |
| EBITDA margin | -32.1% | 51.4% | 47.6% | 46.5% | 46.8% | 11.8% | -9.6% | -14.2% |
| Depreciation | 2.5 | 13.8 | 25.1 | 27.6 | 15.6 | 1.9 | 3.1 | 3.1 |
| EBITA | -107.3 | 229.0 | 209.9 | 173.4 | 180.1 | 12.8 | -10.8 | -15.2 |
| EBITA margin | -32.9% | 48.5% | 42.5% | 40.1% | 43.1% | 10.3% | -13.4% | -17.8% |
| Amortization of intangibles | 24.8 | 158.4 | 130.4 | 72.3 | 53.5 | 5.1 | | |
| EBIT [+] | -132.1 | 70.6 | 79.5 | 101.1 | 126.6 | 7.7 | -10.8 | -15.2 |
| EBIT growth | -287.2% | -11.2% | -21.4% | -20.1% | 1551.7% | -170.7% | -28.8% | -80.1% |
| EBIT margin | -40.5% | 15.0% | 16.1% | 23.4% | 30.3% | 6.2% | -13.4% | -17.8% |
| Non-recurring items [+] | 314.6 | 119.6 | 385.1 | 16.1 | 15.4 | 11.5 | 0.8 | 2.2 |
| Asset impairment | 232.3 | | 319.2 | 15.7 | | | | |
| Loss (gain) on sale of business | | 87.1 | | | | | | |
| In-process research & development | 74.9 | 32.5 | 65.8 | | | | | |
| Interest expense, net [+] | 25.7 | 52.0 | 68.4 | 73.2 | 51.7 | 13.7 | -1.1 | -1.3 |
| Interest expense | 25.7 | 52.0 | 68.4 | 73.2 | 53.3 | 14.7 | | |
| Interest income | | | | | 1.5 | 1.0 | 1.1 | 1.3 |
| Other income (expense), net [+] | 4.7 | -30.7 | -8.2 | 3.3 | -19.6 | 0.2 | 1.0 | -1.5 |
| Gain (loss) on investments | | | | | | | | -1.5 |
| Unrealized gain (loss) on marketable securities | | | | | | | | -1.5 |
| Gain (loss) on debt retirement | | -35.9 | -10.9 | | -10.4 | | | |
| Other | 0.4 | -0.1 | -0.1 | 0.2 | -9.2 | 0.2 | 1.0 | -0.2 |
| Pre-tax income | -467.7 | -131.6 | -382.2 | 15.3 | 39.8 | -17.3 | -9.6 | -17.6 |
| Income taxes | 0.0 | 40.4 | -175.5 | 13.2 | 7.1 | -153.2 | 0.0 | 0.0 |
| Tax rate | 0.0% | | 45.9% | 86.3% | 17.7% | 883.2% | 0.0% | 0.0% |
| Net income | -467.7 | -68.5 | -200.8 | -2.5 | 32.8 | 135.8 | -9.6 | -16.8 |
| Net margin | -143.2% | -14.5% | -40.6% | -0.6% | 7.8% | 109.2% | -11.9% | -19.6% |
| |
| Basic EPS [+] | ($13.74) | ($5.00) | ($5.92) | $0.06 | $1.04 | $6.06 | ($0.44) | ($0.78) |
| Growth | 174.7% | -15.5% | -9816.5% | -94.1% | -82.8% | -1469.5% | -43.5% | -78.5% |
| Diluted EPS [+] | ($13.74) | ($5.00) | ($5.92) | $0.06 | $0.93 | $5.38 | ($0.44) | ($0.78) |
| Growth | 174.7% | -15.5% | -9954.3% | -93.5% | -82.8% | -1317.0% | -43.5% | -78.5% |
| |
| Shares outstanding (basic) [+] | 34.0 | 34.4 | 34.9 | 34.3 | 31.5 | 22.4 | 21.7 | 21.4 |
| Growth | -1.1% | -1.5% | 1.6% | 9.1% | 40.4% | 3.3% | 1.5% | 1.0% |
| Shares outstanding (diluted) [+] | 34.0 | 34.4 | 34.9 | 34.8 | 35.3 | 25.2 | 21.7 | 21.4 |
| Growth | -1.1% | -1.5% | 0.2% | -1.3% | 40.0% | 16.2% | 1.5% | 1.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |